Search
Saturday 27 June 2015
  • :
  • :
Latest Update

Pre-Market Stocks Recap: Hologic, Inc. (NASDAQ:HOLX), RXi Pharmaceuticals Corp (NASDAQ:RXII), Berry Plastics Group Inc (NYSE:BERY), VeriFone Systems Inc (NYSE:PAY)

On Friday, Shares of Hologic, Inc. (NASDAQ:HOLX), gained 1.03% to $38.26, hitti ng its highest level.

Hologic, declared that it has priced its formerly declared private offering of $1.0 billion aggregate principal amount of 5.250% senior notes due 2022 at an issue price of $1,000 per $1,000. The 2022 notes will be unsecured obligations of the Company and will be guaranteed by certain of its direct and indirect auxiliaries. The offering is predictable to close on July 2, 2015, subject to customary closing conditions.

Hologic intends to use the net proceeds of the offering, plus accessible cash, to redeem its outstanding 6.25% senior notes due 2020 in the aggregate principal amount of $1.0 billion.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally.

Shares of RXi Pharmaceuticals Corp (NASDAQ:RXII), inclined 2.60% to $0.4618, during its last trading session.

RXi Pharmaceuticals, declared that it received two Notices of Allowance from the United States Patent and Trademark Office (USPTO). One is on RXi’s novel, self-delivering RNAi platform. The patent, titled “Reduced Size Self-Delivering RNAi Compounds,” covers both the composition and methods of use of RXi’s self-delivering platform. The patent, once issued, will be planned to expire in 2031.

Importantly, this patent expands the scope of RXi’s self-delivering RNAi platform with the incorporation of novel oligonucleotide chemical modifications. These chemical modifications result in improved biodistribution following systemic administration and may be beneficial for local delivery applications in the central nervous system.

RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. The company develops therapies based on siRNA technology and immunotherapy agents.

At the end of Friday’s trade, Shares of Berry Plastics Group Inc (NYSE:BERY), lost -0.29% to $33.90.

Berry Plastics Group, declared that Berry Plastics Corporation, Berry Group’s wholly owned partner, has accomplished its tender offer to purchase any and all of its outstanding 9.75 percent Second Priority Senior Secured Notes due 2021 issued under an indenture dated as of November 19, 2010.

The Tender Offer expired on June 18, 2015 (the “Expiration Date”). No additional Notes were tendered after the expiration of the consent payment deadline on June 4, 2015, at 5:00 p.m., New York City time (the “Consent Date”) and before the Expiration Date. As formerly declared, the Issuer received tenders from holders of $503,186,000 aggregate principal amount of Notes, representing 62.90 percent of the then outstanding Notes. On June 5, 2015, the Issuer accepted for early payment the Notes tendered preceding to the Consent Date.

As formerly declared, the Issuer intends to redeem the Notes that remain outstanding after completion of the Tender Offer in accordance with the terms of the indenture governing the Notes. On June 11, 2015, the Issuer offered notice to the trustee under the indenture of such redemption and irrevocably deposited cash with the trustee in respect of the Notes in an amount sufficient to redeem the outstanding Notes. Citigroup Global Markets Inc. acted as sole dealer manager and solicitation agent in connection with the Tender Offer.

Berry Plastics Group, Inc. manufactures and distributes plastic consumer packaging and engineered materials in North America and internationally. The company operates through four segments: Rigid Open Top, Rigid Closed Top, Engineered Materials, and Flexible Packaging. representing 62.90 percent of the then outstanding Notes. On June 5, 2015, the Issuer accepted for early payment the Notes tendered preceding to the Consent Date.

Finally, VeriFone Systems Inc (NYSE:PAY), ended its last trade with -1.08% loss, and close at $35.82.

Declared during the Apple Worldwide Developers Conference, Apple Pay will support rewards programs from merchants with the fall availability of iOS 9. Verifone (PAY), the global leader in secure electronic payment solutions, will be among the first to enable clients to accept rewards and loyalty information in addition to NFC payments at the terminal via Apple Pay.

To start, Verifone will enable six national and global retailers to be the first to accept NFC loyalty transactions on Verifone’s MX 915 and MX 925 terminals for their consumers to redeem rewards and accrue points.

VeriFone Systems, Inc. designs, markets, and services electronic payment solutions at the point of sale (POS) worldwide. It provides countertop electronic payment systems that accept card payment options, such as NFC, mobile wallets, chip and PIN, and contactless payments, in addition to support credit and debit card, EBT, EMV, and other PIN-based transactions; and a portfolio of application libraries and development tools.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *